QSE:AML 22 February 2026

Qatar Stock Exchange week ahead: FTSE reshuffle, Aamal deal talks and an index cap in focus

The QE Index fell 0.4% to 11,182 in mid-morning trade Sunday, with QLM and Al Meera up, while Qatar Oman Investment and QNB declined. FTSE Russell’s March review will add Zad Holding to micro-cap and drop Qatar National Navigation & Transport from mid-cap, effective March 23. Aamal’s joint venture plans talks to acquire Qatar International Cables. Last week, the market lost 2.5% in value and turnover dropped 11.5%.

22 February 2026

QSE:AML·QSE:ZAD·Stock Market

Innovent Biologics Shares Surge Amid Valuation Debate on SEHK
April 4, 2026, 4:23 AM EDT. Innovent Biologics (SEHK:1801), a Hong Kong-listed biotech firm, has seen a strong share price rally with a 17.9% total return over the last month. Trading at HK$91.5, the company's price-to-sales (P/S) ratio stands at 10.7x, notably below the sector average of 13.6x and peers at 27x, signaling potential undervaluation. Its market cap is HK$158.8 billion, with revenues of CN¥13 billion and net income of CN¥813.6 million. The DCF (discounted cash flow) model estimates a fair value of HK$136.88 per share, suggesting room for further upside. Investors should weigh these positive signals against execution risks and the possibility that optimistic price targets may not be met. The stock's momentum comes as the company advances its global drug pipeline in a competitive biotech landscape.